Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Toby Rogers

Showing results (131-140 of 344) with videos related to

Pageof 35
Sort By:
Journal of Cardiology|October 21, 2024
The impact of ventricular remodeling on quality-of-life outcomes after Transcatheter aortic valve replacementPavan Reddy, Kalyan R Chitturi, Ilan Merdler, et al.
The American Journal of Cardiology|June 13, 2024
Impella Versus Non-Impella for Nonemergent High-Risk Percutaneous Coronary InterventionPavan Reddy, Ilan Merdler, Cheng Zhang, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|April 16, 2019
Adverse events and modes of failure related to the FilterWire EZ Embolic Protection System: Lessons learned from an analytic review of the FDA MAUDE databaseNauman Khalid, Hasan Javed, Toby Rogers, et al.
Echocardiography (Mount Kisco, N.Y.)|April 9, 2021
Pericardiocentesis induced right ventricular changes in patients with and without pulmonary hypertensionHilmi Alnsasra, Brian C Case, Michael Yang, et al.
The American Journal of Cardiology|September 10, 2023
Aspirin Versus Warfarin after Transcatheter Aortic Valve Replacement in Low-Risk Patients: 2-Year Follow-UpIlan Merdler, Toby Rogers, Brian C Case, et al.
Magnetic Resonance in Medicine|April 16, 2021
A 20-gauge active needle design with thin-film printed circuitry for interventional MRI at 0.55TDursun Korel Yildirim, Christopher Bruce, Dogangun Uzun, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|February 28, 2025
Adverse events and failure modes related to Impella CP: Insights from the FDA MAUDE databaseKalyan R Chitturi, Ryan Wallace, Abhishek Chaturvedi, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|August 29, 2024
Impact of left bundle branch block or permanent pacemaker after transcatheter aortic valve replacement on mid-term left ventricular ejection fractionIlan Merdler, Brian C Case, Itsik Ben-Dor, et al.
The American Journal of Cardiology|May 8, 2025
Corrigendum to Impella Versus Non-Impella for Nonemergent High-Risk Percutaneous Coronary Intervention The American Journal of Cardiology (2024) Volume 225, 15 August. Pages 4-9. DOI: 10.1016/j.amjcard.2024.05.038Pavan Reddy, Ilan Merdler, Cheng Zhang, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|August 2, 2020
Guidelines for Balancing Priorities in Structural Heart Disease During the COVID-19 PandemicJaffar M Khan, Nauman Khalid, Evan Shlofmitz, et al.
Pageof 35

Showing results (131-140 of 344) with videos related to

Sort By:
Pageof 35
Journal of Cardiology|October 21, 2024
The impact of ventricular remodeling on quality-of-life outcomes after Transcatheter aortic valve replacementPavan Reddy, Kalyan R Chitturi, Ilan Merdler, et al.
The American Journal of Cardiology|June 13, 2024
Impella Versus Non-Impella for Nonemergent High-Risk Percutaneous Coronary InterventionPavan Reddy, Ilan Merdler, Cheng Zhang, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|April 16, 2019
Adverse events and modes of failure related to the FilterWire EZ Embolic Protection System: Lessons learned from an analytic review of the FDA MAUDE databaseNauman Khalid, Hasan Javed, Toby Rogers, et al.
Echocardiography (Mount Kisco, N.Y.)|April 9, 2021
Pericardiocentesis induced right ventricular changes in patients with and without pulmonary hypertensionHilmi Alnsasra, Brian C Case, Michael Yang, et al.
The American Journal of Cardiology|September 10, 2023
Aspirin Versus Warfarin after Transcatheter Aortic Valve Replacement in Low-Risk Patients: 2-Year Follow-UpIlan Merdler, Toby Rogers, Brian C Case, et al.
Magnetic Resonance in Medicine|April 16, 2021
A 20-gauge active needle design with thin-film printed circuitry for interventional MRI at 0.55TDursun Korel Yildirim, Christopher Bruce, Dogangun Uzun, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|February 28, 2025
Adverse events and failure modes related to Impella CP: Insights from the FDA MAUDE databaseKalyan R Chitturi, Ryan Wallace, Abhishek Chaturvedi, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|August 29, 2024
Impact of left bundle branch block or permanent pacemaker after transcatheter aortic valve replacement on mid-term left ventricular ejection fractionIlan Merdler, Brian C Case, Itsik Ben-Dor, et al.
The American Journal of Cardiology|May 8, 2025
Corrigendum to Impella Versus Non-Impella for Nonemergent High-Risk Percutaneous Coronary Intervention The American Journal of Cardiology (2024) Volume 225, 15 August. Pages 4-9. DOI: 10.1016/j.amjcard.2024.05.038Pavan Reddy, Ilan Merdler, Cheng Zhang, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|August 2, 2020
Guidelines for Balancing Priorities in Structural Heart Disease During the COVID-19 PandemicJaffar M Khan, Nauman Khalid, Evan Shlofmitz, et al.
Pageof 35